Researchers have discovered new genes associated with breast cancer, promising enhanced risk assessment and treatment insights, based on a study of over 240,000 women’s genetic data
A groundbreaking international study led by Professor Jacques Simard from Université Laval and Professor Douglas Easton of the University of Cambridge, UK, has pinpointed new genes correlated with breast cancer. These findings could be integrated into future tests to identify women with heightened risk.
Furthermore, uncovering these novel genes offers invaluable insights into the biological processes that trigger cancer growth, potentially paving the way for innovative new treatments.The overarching objective is to integrate this information into an existing comprehensive risk assessment tool widely adopted by global healthcare experts.
“To our knowledge, this is the largest study of its kind. It was made possible through the use of data from multiple collaborators in many countries, as well as publicly available data from the UK Biobank,” says Professor Douglas Easton, Director of the Centre for Cancer Genetic Epidemiology of the University of Cambridge.